Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma

RT @JNeurooncol: Using data for 100pts, Patel et al @UCLA demonstrate SRS and fSRT are comparable options for tumor control in patients in…

RT @JNeurooncol: Using data for 100pts, Patel et al @UCLA demonstrate SRS and fSRT are comparable options for tumor control in patients in…

@UCLAHealth @UCLAHealthNews @dgsomucla #awesome

Using data for 100pts, Patel et al @UCLA demonstrate SRS and fSRT are comparable options for tumor control in patients in vestibular schwannomas and suggest a cochlear radiation threshold of 5 and 35Gy to preserve hearing after SRS and fSRT, respectively.

RT @IsaacYangMD: Journal of Neuro-Oncology @JNeurooncol Increased cochlear radiation dose predicts delayed hearing loss following both ste…

Journal of Neuro-Oncology @JNeurooncol Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma https://t.co/dTeQm74j3G

https://t.co/dTeQm7lUsg https://t.co/dTeQm7lUsg

Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma. https://t.co/ngYVLhH39x h/t @NCBI #RadOnc #PubMed